Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001520680-13-000001
Filing Date
2013-01-17
Accepted
2013-01-16 17:31:55
Documents
1
Effectiveness Date
2013-01-17
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6359
  Complete submission text file 0001520680-13-000001.txt   7372
Mailing Address 5400 CARILLON POINT KIRKLAND WA 98033
Business Address 5400 CARILLON POINT KIRKLAND WA 98033 425-576-4100
Resolve Therapeutics LLC (Filer) CIK: 0001520680 (see all company filings)

EIN.: 352389247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-190410 | Film No.: 13533122